Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities

被引：52
作者：
Fulda, S. [1 ]
机构：
[1] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany
来源：
LEUKEMIA | 2014年 / 28卷 / 07期
关键词：
NF-KAPPA-B; ACUTE MYELOID-LEUKEMIA; X-LINKED INHIBITOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; XIAP ANTISENSE OLIGONUCLEOTIDE; ALPHA-DEPENDENT APOPTOSIS; CASPASE-MEDIATED CLEAVAGE; CELL-DEATH; MULTIPLE-MYELOMA; STRUCTURAL BASIS;
D O I：
10.1038/leu.2014.56
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Inhibitor of Apoptosis (IAP) proteins exert essential functions during tumorigenesis as well as treatment resistance by simultaneously blocking cell death pathways and promoting cell survival. As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions. There are currently exciting opportunities to rationally exploit the therapeutic targeting of IAP proteins for the treatment of leukemia and lymphoma. Further insights into the signaling pathways that are under the control of IAP proteins and into the specific IAP protein-dependent vulnerabilities of hematological neoplasms are expected to pave the avenue to novel treatment strategies.
引用
收藏
页码：1414 / 1422
页数：9
相关论文
共 50 条
  • [21] A novel therapeutic approach for hematological malignancies based on cellular differentiation and apoptosis
    Masahiro Kizaki
    Tomonori Nakazato
    Keisuke Ito
    Chiharu Kawamura
    Yoshitaka Miyakawa
    Yasuo Ikeda
    International Journal of Hematology, 2002, 76 : 250 - 252
  • [22] Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
    Farnault, Laure
    Sanchez, Carole
    Baier, Celine
    Le Treut, Therese
    Costello, Regis T.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [23] Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities
    Irwin, Mary E.
    Rivera-Del Valle, Nilsa
    Chandra, Joya
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (11) : 1349 - 1383
  • [24] Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
    Miljkovic, Djordje
    Spasojevic, Ivan
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (18) : 2286 - 2334
  • [25] Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
    Flygare, John A.
    Beresini, Maureen
    Budha, Nageshwar
    Chan, Helen
    Chan, Iris T.
    Cheeti, Sravanthi
    Cohen, Frederick
    Deshayes, Kurt
    Doerner, Karl
    Eckhardt, S. Gail
    Elliott, Linda O.
    Feng, Bainian
    Franklin, Matthew C.
    Reisner, Stacy Frankovitz
    Gazzard, Lewis
    Halladay, Jason
    Hymowitz, Sarah G.
    La, Hank
    LoRusso, Patricia
    Maurer, Brigitte
    Murray, Lesley
    Plise, Emile
    Quan, Clifford
    Stephan, Jean-Philippe
    Young, Shin G.
    Tom, Jeffrey
    Tsui, Vickie
    Um, Joanne
    Varfolomeev, Eugene
    Vucic, Domagoj
    Wagner, Andrew J.
    Wallweber, Heidi J. A.
    Wang, Lan
    Ware, Joseph
    Wen, Zhaoyang
    Wong, Harvey
    Wong, Jonathan M.
    Wong, Melisa
    Wong, Susan
    Yu, Ron
    Zobel, Kerry
    Fairbrother, Wayne J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (09) : 4101 - 4113
  • [26] In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
    Ohoka, Nobumichi
    Okuhira, Keiichiro
    Ito, Masahiro
    Nagai, Katsunori
    Shibata, Norihito
    Hattori, Takayuki
    Ujikawa, Osamu
    Shimokawa, Kenichiro
    Sano, Osamu
    Koyama, Ryokichi
    Fujita, Hisashi
    Teratani, Mika
    Matsumoto, Hirokazu
    Imaeda, Yasuhiro
    Nara, Hiroshi
    Cho, Nobuo
    Naito, Mikihiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (11) : 4556 - 4570
  • [27] Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities
    Comhair, Suzy A. A.
    Erzurum, Serpil C.
    ANTIOXIDANTS & REDOX SIGNALING, 2010, 12 (01) : 93 - 124
  • [28] Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
    Kuo, Macus Tien
    ANTIOXIDANTS & REDOX SIGNALING, 2009, 11 (01) : 99 - 133
  • [29] Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain
    Donnell, Andrew F.
    Michoud, Christophe
    Rupert, Kenneth C.
    Han, Xiaochun
    Aguilar, Douglas
    Frank, Karl B.
    Fretland, Adrian J.
    Gao, Lin
    Goggin, Barry
    Hogg, J. Heather
    Hong, Kyoungja
    Janson, Cheryl A.
    Kester, Robert F.
    Kong, Norman
    Le, Kang
    Li, Shirley
    Liang, Weiling
    Lombardo, Louis J.
    Lou, Yan
    Lukacs, Christine M.
    Mischke, Steven
    Moliterni, John A.
    Polonskaia, Ann
    Schutt, Andrew D.
    Solis, Dave S.
    Specian, Anthony
    Taylor, Robert T.
    Weisel, Martin
    Remiszewski, Stacy W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (20) : 7772 - 7787
  • [30] Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management
    Barachini, Serena
    Buda, Gabriele
    Petrini, Iacopo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
12345